Industry

In Other News

• New Automated Hemostasis Systems Become Available Across US Laboratories

• ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

• CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

• Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

• Unilabs Expands Digital Pathology Across European Network with Proscia Platform

• MGI Launches Automated Multiplex Tissue Staining and Imaging System at ECP 2026

• Digital Pathology Partnership Integrates Breast Cancer Diagnostic and Prognostic Tools

• Blood-Based Neurology Biomarker Assays Authorized for Use in Brazil

• Sepsis Diagnostics Market Growth Fueled by Faster Pathogen Detection Needs

• Project Advances Single-Cell Diagnostic Test for Triple-Negative Breast Cancer

• Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

• Health Canada Licenses Point-of-Care Hematology Analyzer for Decentralized CBC Testing

• FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

• New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers

• Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada

• Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment

• Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial

• Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

• Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

• Global Urinalysis Market Gowth Driven by Demand for Automated and POC Testing

• New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

• FDA Clears Roche Blood Test for Alzheimer’s Amyloid Pathology Assessment

• Autonomous Robotic System Receives FDA Authorization for Blood Collection